Cargando…
Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
Advances in molecular tumour diagnostics and the number of targeted therapies increase rapidly. Molecular tumour boards (MTBs) are designated to interpret these data and provide clinical recommendations. Not all patients with cancer have access to advice of an MTB. We aimed to determine the current...
Autores principales: | Willemsen, Annelieke E. C. A. B., Krausz, Sarah, Ligtenberg, Marjolijn J. L., Grünberg, Katrien, Groen, Harry J. M., Voest, Emile E., Cuppen, Edwin P. J. G., van Laarhoven, Hanneke W. M., van Herpen, Carla M. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738039/ https://www.ncbi.nlm.nih.gov/pubmed/31130724 http://dx.doi.org/10.1038/s41416-019-0489-3 |
Ejemplares similares
-
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020) -
Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2021) -
Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2022) -
Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine
por: van de Haar, Joris, et al.
Publicado: (2019) -
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands
por: Wolff, Henri B., et al.
Publicado: (2022)